Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The Journal of Biological Chemistry|December 24, 2024
ID3 promotes erythroid differentiation and is repressed by a TAL1-PRMT6 complexVivien Heller, Lei Wang, Edith Schneider, et al.
Experimental Hematology|September 14, 2016
MicroRNA-155 is upregulated in MLL-rearranged AML but its absence does not affect leukemia developmentEdith Schneider, Anna Staffas, Linda Röhner, et al.
Cancers|December 23, 2022
Development of Allogeneic Stem Cell-Based Platform for Delivery and Potentiation of Oncolytic VirotherapyDuong Hoang Nguyen, Thomas Herrmann, Barbara Härtl, et al.
Blood Advances|January 4, 2018
A knock-in mouse strain facilitates dynamic tracking and enrichment of MEIS1Ping Xiang, Wei Wei, Nicole Hofs, et al.
Oncotarget|December 10, 2017
<i>Protein phosphatase 4 regulatory subunit 2 (PPP4R2)</i> is recurrently deleted in acute myeloid leukemia and required for efficient DNA double strand break repairJulia K Herzig, Lars Bullinger, Alpaslan Tasdogan, et al.
Plos One|July 24, 2020
Drug targeting CYP2E1 for the treatment of early-stage alcoholic steatohepatitisTorsten Diesinger, Vyacheslav Buko, Alfred Lautwein, et al.
Canadian Journal of Gastroenterology & Hepatology|February 19, 2021
A New CYP2E1 Inhibitor, 12-Imidazolyl-1-dodecanol, Represents a Potential Treatment for Hepatocellular CarcinomaTorsten Diesinger, Alfred Lautwein, Sebastian Bergler, et al.
Leukemia|May 27, 2022
Elucidating the importance and regulation of key enhancers for human MEIS1 expressionPing Xiang, Xining Yang, Leo Escano, et al.
Haematologica|December 9, 2017
Micro-ribonucleic acid-155 is a direct target of Meis1, but not a driver in acute myeloid leukemiaEdith Schneider, Anna Staffas, Linda Röhner, et al.
Leukemia|November 27, 2019
MicroRNA-708 is a novel regulator of the Hoxa9 program in myeloid cellsEdith Schneider, Nicole Pochert, Christoph Ruess, et al.
Pageof 2